Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL704751 | 0.89 | — | — | |
| SCHEMBL28470623 | 0.81 | KCNH2 (0.37) | KCNH2LTA4HTP53ALDH1A1PIN1 | |
| SCHEMBL707481 | 0.77 | ALDH1A1 (0.31) | MAPK1ALDH1A1 | |
| SCHEMBL8679106 | 0.76 | CHRNB2 (0.38) | ALDH1A1 | |
| SCHEMBL3063901 | 0.76 | MAPK1 (0.36) | LTA4HMAPK1ALDH1A1ALOX15 | |
| SCHEMBL9066519 | 0.73 | TP53 (0.31) | TP53 | |
| SCHEMBL27943103 | 0.71 | TP53 (0.35) | MAPK1TP53TAAR1ALDH1A1SLC6A2 | |
| SCHEMBL15147452 | 0.71 | RIPK1 (0.35) | MAPK1TP53TAAR1ALDH1A1SLC6A2 | |
| SCHEMBL825909 | 0.69 | NPSR1 (0.37) | LTA4HALDH1A1 | |
| SCHEMBL229796 | 0.69 | L3MBTL1 (0.32) | KCNH2LTA4HTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109880104-B | Preparation method of phosphorus-based organic silicon type flame retardant | 普信氟硅新材料（衢州）有限公司 | 2021-05-28 | — | — | CN | claimed |
| US-9216952-B2 | Process for preparing antiviral compound | ABBVIE INC. (US) | 2015-12-22 | — | — | US | claimed |
| EP-2411372-B1 | PROCESS FOR PREPARING AN ANTIVIRAL COMPOUND | ABBVIE BAHAMAS LTD (BS) | 2014-07-23 | — | — | EP | claimed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | claimed |
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2011-09-29 | — | — | US | claimed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | claimed |
| EP-3336059-B1 | POLYMER-GRAPHENE COMPOSITE, METHOD FOR PREPARING SAME, AND A POLYMER-GRAPHENE COMPOSITE COMPOSITION USING SAME | LG CHEMICAL LTD (KR) | 2022-10-12 | — | — | EP | disclosed |
| CN-108025916-B | Polymer-graphene composite material, method for preparing same, and polymer-graphene composite composition using same | 株式会社LG化学 | 2022-04-12 | — | — | CN | disclosed |
| US-11198752-B2 | Polymer-graphene composite, method for preparing same, and polymer-graphene composite composition using same | LG CHEM, LTD. | 2021-12-14 | — | — | US | disclosed |
| WO-2021122431-A1 | POLYURETHANE FOAMS BASED ON POLYETHER CARBONATE POLYOLS | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2021-06-24 | — | — | WO | disclosed |
| CN-109880104-B | Preparation method of phosphorus-based organic silicon type flame retardant | 普信氟硅新材料（衢州）有限公司 | 2021-05-28 | — | — | CN | disclosed |
| US-20190085114-A1 | POLYMER-GRAPHENE COMPOSITE, METHOD FOR PREPARING SAME, AND POLYMER-GRAPHENE COMPOSITE COMPOSITION USING SAME | LG CHEM, LTD. (KR) | 2019-03-21 | — | — | US | disclosed |
| EP-3336059-A1 | POLYMER-GRAPHENE COMPOSITE, METHOD FOR PREPARING SAME, AND A POLYMER-GRAPHENE COMPOSITE COMPOSITION USING SAME | LG Chem, Ltd. (KR) | 2018-06-20 | — | — | EP | disclosed |
| US-9802903-B2 | Process for preparing antiviral compound | ABBVIE INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-20160060228-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES | 2016-03-03 | — | — | US | disclosed |
| US-9216952-B2 | Process for preparing antiviral compound | ABBVIE INC. (US) | 2015-12-22 | — | — | US | disclosed |
| EP-2411372-B1 | PROCESS FOR PREPARING AN ANTIVIRAL COMPOUND | ABBVIE BAHAMAS LTD (BS) | 2014-07-23 | — | — | EP | disclosed |
| EP-2411372-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | Abbott Laboratories (US) | 2012-02-01 | — | — | EP | disclosed |
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2011-09-29 | — | — | US | disclosed |
| WO-2010111348-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ABBOTT LABORATORIES (US) | 2010-09-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110237793-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ZC3HAV1, HAVCR2, MAVS | KCNH2 3122/4885LTA4H 2743/4885MAPK1 2356/4885 |
| US-20160060228-A1 | PROCESS FOR PREPARING ANTIVIRAL COMPOUND | ZC3HAV1, HAVCR2, MAVS | KCNH2 3122/4885LTA4H 2743/4885MAPK1 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.